Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
14.50
+0.24 (1.68%)
Apr 14, 2026, 9:53 AM EDT - Market open
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $1.71 billion as of April 14, 2026. Its market cap has increased by 97.00% in one year.
Market Cap
1.71B
Enterprise Value
1.17B
1-Year Change
97.00%
Ranking
Category
Stock Price
$14.50
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $1.71B, an increase of 126.13%. That is a compound annual growth rate of 8.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 1.68B | 61.78% |
| Dec 31, 2025 | 1.04B | -12.32% |
| Dec 31, 2024 | 1.19B | -56.51% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
| May 6, 2016 | 757.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Harmony Biosciences Holdings | 1.67B |
| Nurix Therapeutics | 1.66B |
| Rapport Therapeutics | 1.63B |
| Oculis Holding AG | 1.62B |
| Nuvation Bio | 1.58B |
| Immunocore Holdings | 1.57B |
| Damora Therapeutics | 1.56B |
| Viridian Therapeutics | 1.53B |